Loading...

APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103115 25 µg 98 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg 196 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Heindl S, et al. 2021. J Exp Med. 218:. PubMed
  2. Stefkovich M, et al. 2021. Mol Metab. 54:101357. PubMed
  3. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  4. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  5. De Vries LCS, et al. 2021. J Crohns Colitis. 15:617. PubMed
  6. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  7. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  8. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  9. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  10. Ren D, et al. 2022. STAR Protoc. 3:101217. PubMed
  11. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  12. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  13. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  14. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  15. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  16. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  17. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  18. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  19. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  20. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  21. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  22. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  23. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  24. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  25. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  26. Urban SK, et al. 2020. Liver Int. 40:3103. PubMed
  27. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  28. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  29. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  30. Page N, et al. 2018. Immunity. 48:937. PubMed
  31. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  32. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  33. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  34. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  35. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  36. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  37. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  38. Baram T, et al. 2021. Cells. 10:. PubMed
  39. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  40. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  41. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  42. Adrover JM, et al. 2022. JCI Insight. 7:. PubMed
  43. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  44. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  45. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
  46. Zhu S, et al. 2022. Front Pharmacol. 13:996635. PubMed
  47. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  48. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  49. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  50. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  51. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  52. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  53. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  54. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  55. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  56. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  57. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  58. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  59. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  60. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  61. Biswas S, et al. 2021. Nature. 591:464. PubMed
  62. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  63. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  64. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  65. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  66. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  67. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  68. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  69. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  70. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  71. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  72. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  73. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  74. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  75. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  76. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  77. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  78. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  79. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  80. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  81. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  82. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  83. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  84. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  85. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  86. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  87. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  88. Schönfeld M, et al. 2021. Alcohol Clin Exp Res. 45:1980. PubMed
  89. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  90. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  91. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  92. Marangoni F, et al. 2021. Cell. . PubMed
  93. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  94. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  95. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  96. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  97. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  98. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  99. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  100. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  101. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  102. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  103. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  104. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  105. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
  106. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  107. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  108. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  109. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  110. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  111. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  112. Commerford CD et al. 2018. Cell reports. . PubMed
  113. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  114. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  115. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  116. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  117. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  118. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  119. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  120. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  121. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  122. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  123. Gao H, et al. 2021. Cells. 10:. PubMed
  124. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  125. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  126. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  127. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  128. Zhang X, et al. 2020. Elife. 9:00. PubMed
  129. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  130. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  131. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  132. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  133. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  134. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  135. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  136. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  137. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  138. Ali M, et al. 2022. JCI Insight. 7:. PubMed
  139. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  140. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  141. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  142. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  143. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  144. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  145. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  146. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  147. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  148. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  149. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  150. Neuhöfer P, et al. 2021. Nature. 597:715. PubMed
  151. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  152. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  153. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  154. Selvaraj UM, et al. 2021. Brain Behav Immun. 95:502. PubMed
  155. Ying T, et al. 2021. Am J Physiol Endocrinol Metab. 320:E1148. PubMed
  156. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  157. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  158. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  159. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  160. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  161. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  162. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  163. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  164. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  165. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  166. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  167. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  168. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  169. Yang Y, et al. 2022. Elife. 11:. PubMed
  170. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  171. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  172. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  173. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  174. Cardenas JJ, et al. 2020. Methods Enzymol. 415:631. PubMed
  175. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  176. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  177. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  178. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  179. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  180. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  181. Clement CC, et al. 2021. Nat Commun. 12:4447. PubMed
  182. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  183. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  184. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  185. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  186. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  187. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  188. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  189. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  190. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  191. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  192. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  193. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  194. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  195. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  196. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  197. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  198. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  199. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  200. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  201. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  202. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  203. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  204. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  205. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  206. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  207. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  208. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  209. Wang X, et al. 2022. Front Immunol. 13:864984. PubMed
  210. Galani IE, et al. 2022. STAR Protoc. 3:101151. PubMed
  211. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  212. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  213. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  214. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  215. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  216. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  217. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  218. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  219. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  220. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  221. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  222. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  223. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  224. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  225. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  226. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  227. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  228. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  229. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  230. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  231. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  232. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  233. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  234. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  235. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  236. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  237. Pedicone C, et al. 2022. iScience. 25:104170. PubMed
  238. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  239. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  240. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  241. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  242. Milich LM, et al. 2021. J Exp Med. 218:. PubMed
  243. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  244. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  245. Starikova E, et al. 2021. Front Pharmacol. 12:667572. PubMed
  246. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  247. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  248. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  249. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  250. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  251. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  252. Morein D, et al. 2021. Cells. 10: . PubMed
  253. Yan C, et al. 2022. NPJ Precis Oncol. 6:6. PubMed
  254. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  255. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  256. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  257. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  258. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  259. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  260. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  261. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  262. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  263. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  264. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  265. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  266. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  267. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  268. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  269. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  270. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  271. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  272. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  273. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  274. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  275. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  276. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  277. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  278. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  279. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  280. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  281. Liu SS, et al. 2021. Immunity. :. PubMed
  282. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  283. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  284. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  285. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  286. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  287. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  288. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  289. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  290. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  291. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  292. Sibler E, et al. 2021. Cells. 10:. PubMed
  293. Oladiran O, et al. 2021. Front Immunol. 12:720733. PubMed
  294. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  295. Sebastian A, et al. 2021. Cells. 10:. PubMed
  296. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  297. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  298. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  299. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  300. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  301. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  302. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  303. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  304. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  305. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  306. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  307. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  308. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  309. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  310. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  311. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  312. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  313. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
  314. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  315. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  316. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  317. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  318. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  319. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  320. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  321. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  322. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  323. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 01.30.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account